Cited by 1,974Inflammatory mediators and NSAID effectsImmune cells in cancerInflammatory Bowel Disease

The DOI matches its Crossref record; 243 of the 247 references it cites were found in a registry or an index.

Inflammation and Colon Cancer

Terzić, Janoš, Grivennikov, Sergei, Karin, Eliad, Karin, Michael·2010·Gastroenterology

DOI 10.1053/j.gastro.2010.01.058

Open this paper in CoChat — free account

Abstract

The connection between inflammation and tumorigenesis is well-established and in the last decade has received a great deal of supporting evidence from genetic, pharmacological, and epidemiological data. Inflammatory bowel disease is an important risk factor for the development of colon cancer. Inflammation is also likely to be involved with other forms of sporadic as well as heritable colon cancer. The molecular mechanisms by which inflammation promotes cancer development are still being uncovered and could differ between colitis-associated and other forms of colorectal cancer. Recent work has elucidated the role of distinct immune cells, cytokines, and other immune mediators in virtually all steps of colon tumorigenesis, including initiation, promotion, progression, and metastasis. These mechanisms, as well as new approaches to prevention and therapy, are discussed in this review.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2010.01.058

Cites

243 of 243 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Cancer-related inflammation
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Self-citation
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Cancer Statistics, 2008
Jemal, A., Siegel, R. L., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,184
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Myeloid-derived-suppressor cells as regulators of the immune system
Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383

Show all 247 references

Sorted by citations

NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679
Self-citation
Designing and developing a literature-derived, population-based dietary inflammatory index
Shivappa, N., Steck, S. E., Hurley, T. G., Hussey, J. R., & Hébert, J. R. (2014) · Public Health Nutrition · doi:10.1017/s1368980013002115 · Cited by 2,731
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
Bhattacharyya, A., Chattopadhyay, R., Mitra, S., & Crowe, S. E. (2014) · Physiological Reviews · doi:10.1152/physrev.00040.2012 · Cited by 2,484
Inflammation meets cancer, with NF-κB as the matchmaker
Ben‐Neriah, Y., & Karin, M. (2011) · Nature Immunology · doi:10.1038/ni.2060 · Cited by 1,412
Self-citation
Adenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327
Self-citation
Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers
Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., Jia, W., Cai, S., & Zhao, L. (2012) · The ISME Journal · doi:10.1038/ismej.2011.109 · Cited by 1,287
NF-κB, an Active Player in Human Cancers
Xia, Y., Shen, S., & Verma, I. M. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0112 · Cited by 1,213
Intestinal Inflammation and Cancer
Ullman, T. A., & Itzkowitz, S. H. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.057 · Cited by 1,127
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
Zhang, M., Viennois, É., Prasad, M. A., Zhang, Y., Wang, L., Zhang, Z., Han, M. K., Xiao, B., Xu, C., Srinivasan, S., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.018 · Cited by 1,071
IL-6R/STAT3/miR-34a feedback loop promotes EMT-mediated colorectal cancer invasion and metastasis
Rokavec, M., Öner, M. G., Li, H., Jackstadt, R., Jiang, L., Lodygin, D., Kaller, M., Horst, D., Ziegler, P. K., Schwitalla, S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73531 · Cited by 753
IL-6 and related cytokines as the critical lynchpins between inflammation and cancer
Taniguchi, K., & Karin, M. (2014) · Seminars in Immunology · doi:10.1016/j.smim.2014.01.001 · Cited by 724
Self-citation
A population-based dietary inflammatory index predicts levels of C-reactive protein in the Seasonal Variation of Blood Cholesterol Study (SEASONS)
Shivappa, N., Steck, S. E., Hurley, T. G., Hussey, J. R., Ma, Y., Ockene, I. S., Tabung, F. K., & Hébert, J. R. (2013) · Public Health Nutrition · doi:10.1017/s1368980013002565 · Cited by 724
Immunity, inflammation, and cancer: an eternal fight between good and evil
Shalapour, S., & Karin, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci80007 · Cited by 713
Self-citation
Nutrients, foods, and colorectal cancer prevention
Song, M., Garrett, W. S., & Chan, A. T. (2015) · Gastroenterology · doi:10.1053/j.gastro.2014.12.035 · Cited by 700
NF-κB: At the Borders of Autoimmunity and Inflammation
Barnabei, L., Laplantine, E., Mbongo, W., Rieux‐Laucat, F., & Weil, R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716469 · Cited by 660
Genetic and biological hallmarks of colorectal cancerPreprint
Li, J., Ma, X., Chakravarti, D., Shalapour, S., & DePinho, R. A. (2021) · Genes & Development · doi:10.1101/gad.348226.120 · Cited by 617
NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer
Couturier-Maillard, A., Sécher, T., Rehman, A., Normand, S., Arcangelis, A. D., Häsler, R., Huot, L., Grandjean, T., Bressenot, A., Delanoye, A., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62236 · Cited by 571
Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer
Allin, K. H., & Nordestgaard, B. G. (2011) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2011.599831 · Cited by 563
Inflammation and colorectal cancer: colitis-associated neoplasia
Grivennikov, S. I. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0352-6 · Cited by 574
Self-citation
Association between dietary inflammatory index and inflammatory markers in the HELENA study
Shivappa, N., Hébert, J. R., Marcos, A., Díaz, L. E., Gómez‐Martínez, S., Nova, E., Michels, N., Arouca, A. B., González‐Gil, E. M., Gottrand, F., et al. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600707 · Cited by 554
Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis
Tojo, R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i41.15163 · Cited by 533
NF-κB in inflammation and cancer
Mao, H., Zhao, X., & Sun, S. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01310-w · Cited by 601
Cancer and Inflammation: An Old Intuition with Rapidly Evolving New Concepts
Trinchieri, G. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075008 · Cited by 522
Inflammation and Intestinal Metaplasia of the Distal Esophagus Are Associated With Alterations in the Microbiome
Yang, L., Lü, X., Nossa, C. W., François, F., Peek, R. M., & Pei, Z. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.04.046 · Cited by 494
Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage
Grivennikov, S. I., & Karin, M. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.140145 · Cited by 560
Self-citation
Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer
Cooks, T., Pateras, I. S., Tarcic, O., Solomon, H., Schetter, A. J., Wilder, S., Lozano, G., Pikarsky, E., Forshew, T., Rozenfeld, N., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.03.022 · Cited by 478
Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon
Guo, C., Guo, D., Fang, L., Sang, T., Wu, J., Guo, C., Wang, Y., Wang, Y., Chen, C., Chen, J., et al. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118231 · Cited by 480
Associations between dietary inflammatory index and inflammatory markers in the Asklepios Study
Shivappa, N., Hébert, J. R., Rietzschel, E. R., Buyzere, M. D., Langlois, M. R., Debruyne, E., Marcos, A., & Huybrechts, I. (2015) · British Journal Of Nutrition · doi:10.1017/s000711451400395x · Cited by 464
Molecular Pathways Involved in Colorectal Cancer: Implications for Disease Behavior and Prevention
Colussi, D., Brandi, G., Bazzoli, F., & Ricciardiello, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140816365 · Cited by 429
Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
Triantafillidis, J. K., Nasioulas, G., & Kosmidis, P. (2009) · PubMed · Cited by 425
The NOD-Like Receptor NLRP12 Attenuates Colon Inflammation and Tumorigenesis
Zaki, H., Vogel, P., Malireddi, R. K. S., Body–Malapel, M., Anand, P., Bertin, J., Green, D. R., Lamkanfi, M., & Kanneganti, T. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.10.022 · Cited by 419
RNA m6A methylation orchestrates cancer growth and metastasis via macrophage reprogramming
Yin, H., Zhang, X., Yang, P., Zhang, X., Peng, Y., Li, D., Yu, Y., Wu, Y., Wang, Y., Zhang, J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21514-8 · Cited by 412
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials
Fucà, G., Guarini, V., Antoniotti, C., Morano, F., Moretto, R., Corallo, S., Marmorino, F., Lonardi, S., Rimassa, L., Bianchi, A. S., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0894-7 · Cited by 427
Obesity and cancer: inflammation bridges the two
Kolb, R. H., Sutterwala, F. S., & Zhang, W. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.07.005 · Cited by 431
Chronic intestinal inflammation: inflammatory bowel disease and colitis-associated colon cancer
Rubin, D. C., Shaker, A., & Levin, M. S. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00107 · Cited by 421
Chemotherapy: a double-edged sword in cancer treatment
Behranvand, N., Nasri, F., Emameh, R. Z., Khani, P., Hosseini, A., Garssen, J., & Falak, R. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-03013-3 · Cited by 454
Innate immune mechanisms of colitis and colitis-associated colorectal cancer
Saleh, M., & Trinchieri, G. (2010) · Nature reviews. Immunology · doi:10.1038/nri2891 · Cited by 406
Occurrence of Tertiary Lymphoid Tissue Is Associated with T-Cell Infiltration and Predicts Better Prognosis in Early-Stage Colorectal Cancers
Caro, G. D., Bergomas, F., Grizzi, F., Doni, A., Bianchi, P. P., Malesci, A., Laghi, L., Allavena, P., Mantovani, A., & Marchesi, F. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2590 · Cited by 402
Inflammatory Bowel Disease: An Expanding Global Health Problem
M’Koma, A. E. (2013) · Clinical Medicine Insights Gastroenterology · doi:10.4137/cgast.s12731 · Cited by 380
Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC
Satoh, K., Yachida, S., Sugimoto, M., Oshima, M., Nakagawa, T., Akamoto, S., Tabata, S., Saitoh, K., Kato, K., Sato, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1710366114 · Cited by 364
Nod-like receptor pyrin domain-containing protein 6 (NLRP6) controls epithelial self-renewal and colorectal carcinogenesis upon injury
Normand, S., Delanoye, A., Bressenot, A., Huot, L., Grandjean, T., Peyrin‐Biroulet, L., Lemoine, Y., Hot, D., & Chamaillard, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100981108 · Cited by 374
Regulation of inflammation by interleukin-4: a review of "alternatives"
Luzina, I. G., Keegan, A. D., Heller, N. M., Rook, G. A. W., Shea-Donohue, T., & Atamas, S. P. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0412214 · Cited by 351
Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer
Ladoire, S., Martin, F., & Ghiringhelli, F. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1046-y · Cited by 347
The Hippo pathway in intestinal regeneration and disease
Hong, A. W., Meng, Z., & Guan, K. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.59 · Cited by 330
Tumor-associated Macrophages (TAM) and Inflammation in Colorectal Cancer
Erreni, M., Mantovani, A., & Allavena, P. (2010) · Cancer Microenvironment · doi:10.1007/s12307-010-0052-5 · Cited by 336
Physical activity and autoimmune diseases: Get moving and manage the disease
Sharif, Κ., Watad, ‬., Bragazzi, N. L., Lichtbroun, M., Amital, H., & Shoenfeld, Y. (2017) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.11.010 · Cited by 342
Microbiota, Inflammation and Colorectal Cancer
Lucas, C., Barnich, N., & Nguyen, H. T. T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061310 · Cited by 330
Small molecule-driven mitophagy-mediated NLRP3 inflammasome inhibition is responsible for the prevention of colitis-associated cancer
Guo, W., Sun, Y., Liu, W., Wu, X., Guo, L., Cai, P., Wu, X., Wu, X., Shen, Y., Shu, Y., et al. (2014) · Autophagy · doi:10.4161/auto.28374 · Cited by 303
MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice
Perera, A. P., Fernando, R., Shinde, T., Gundamaraju, R., Southam, B., Sohal, S. S., Robertson, A. A. B., Schroder, K., Kunde, D., & Eri, R. D. (2018) · Scientific Reports · doi:10.1038/s41598-018-26775-w · Cited by 306
Blockade of dendritic cell development by bacterial fermentation products butyrate and propionate through a transporter (Slc5a8)-dependent inhibition of histone deacetylases
Singh, N., Thangaraju, M., Prasad, P. D., Martin, P. M., Lambert, N. A., Boettger, T., Offermanns, S., & Ganapathy, V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.102947 · Cited by 293
Immunotherapy, Inflammation and Colorectal Cancer
Lichtenstern, C. R., Ngu, R. K., Shalapour, S., & Karin, M. (2020) · Cells · doi:10.3390/cells9030618 · Cited by 296
Self-citation
Current status of interleukin-10 and regulatory T-cells in cancer
Dennis, K. L., Blatner, N. R., Gounari, F., & Khazaie, K. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0000000000000006 · Cited by 289
Inflammation-Induced Tumorigenesis and Metastasis
Hibino, S., Kawazoe, T., Kasahara, H., Itoh, S., Ishimoto, T., Sakata‐Yanagimoto, M., & Taniguchi, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115421 · Cited by 319
Targeting the NFκB Signaling Pathways for Breast Cancer Prevention and Therapy
Wang, W., Nag, S. A., & Zhang, R. (2014) · Current Medicinal Chemistry · doi:10.2174/0929867321666141106124315 · Cited by 287
The Intestinal Stem Cell Niche: Homeostasis and Adaptations
Santos, A. J. M., Lo, Y., Mah, A. T., & Kuo, C. J. (2018) · Trends in Cell Biology · doi:10.1016/j.tcb.2018.08.001 · Cited by 290
LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis.
Hsu, R. Y., Chan, C., Spicer, J., Rousseau, M., Giannias, B., Rousseau, S., & Ferri, L. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2833 · Cited by 270
AOM/DSS Model of Colitis-Associated Cancer
Parang, B., Barrett, C. W., & Williams, C. S. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3603-8_26 · Cited by 279
NLRC5/MHC class I transactivator is a target for immune evasion in cancer
Yoshihama, S., Roszik, J., Downs, I., Meissner, T. B., Vijayan, S., Chapuy, B., Sidiq, T., Shipp, M. A., Lizee, G. A., & Kobayashi, K. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602069113 · Cited by 276
Potential of probiotics, prebiotics and synbiotics for management of colorectal cancer
Raman, M., Ambalam, P. S., Kondepudi, K. K., Pithva, S. P., Kothari, C., Patel, A. T., Purama, R. K., Dave, J. M., & Vyas, B. R. M. (2013) · Gut Microbes · doi:10.4161/gmic.23919 · Cited by 276
Interplay between diet, gut microbiota, epigenetic events, and colorectal cancer
Bultman, S. J. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500902 · Cited by 275
Epidemiological transition of colorectal cancer in developing countries: Environmental factors, molecular pathways, and opportunities for prevention
Bishehsari, F. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i20.6055 · Cited by 277
Perspective: Alpha-Bugs, Their Microbial Partners, and the Link to Colon Cancer
Sears, C. L., & Pardoll, D. M. (2011) · The Journal of Infectious Diseases · doi:10.1093/jinfdis/jiq061 · Cited by 259
Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome
Li, H., Guan, Y., Liang, B., Ding, P., Hou, X., Wei, W., & Ma, Y. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175091 · Cited by 258
Epigenetics and Colorectal Cancer Pathogenesis
Bardhan, K., & Liu, K. (2013) · Cancers · doi:10.3390/cancers5020676 · Cited by 266
The intestinal microbiota, gastrointestinal environment and colorectal cancer: a putative role for probiotics in prevention of colorectal cancer?
Azcárate-Peril, M. A., Sikes, M. L., & Bruno-Bárcena, J. M. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00110.2011 · Cited by 260
Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice
Bersudsky, M., Luski, L., Fishman, D., White, R. M., Ziv‐Sokolovskaya, N., Dotan, S., Rider, P., Kaplanov, I., Aychek, T., Dinarello, C. A., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-303329 · Cited by 256
Lifestyle Medicine: A Brief Review of Its Dramatic Impact on Health and Survival
Bodai, B. I., Nakata, T. E., Wong, W. T., Clark, D. R., Lawenda, S., Tsou, C., Liu, R., Shiue, L., Cooper, N., Rehbein, M., et al. (2018) · The Permanente Journal · doi:10.7812/tpp/17-025 · Cited by 253
NF-κB pathways in the development and progression of colorectal cancer
Patel, M., Horgan, P. G., McMillan, D. C., & Edwards, J. (2018) · Translational research · doi:10.1016/j.trsl.2018.02.002 · Cited by 254
Colorectal Cancer in the Young: Epidemiology, Prevention, Management
Siegel, R. L., Jakubowski, C. D., Fedewa, S. A., Davis, A., & Azad, N. S. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_279901 · Cited by 252
Infection-induced colitis in mice causes dynamic and tissue-specific changes in stress response and DNA damage leading to colon cancer
Mangerich, A., Knutson, C. G., Parry, N. M., Muthupalani, S., Ye, W., Prestwich, E. G., Liang, C., McFaline‐Figueroa, J. L., Mobley, M. W., Ge, Z., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1207829109 · Cited by 248
Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma
Kantola, T., Klintrup, K., Väyrynen, J. P., Vornanen, J., Bloigu, R., Karhu, T., Herzig, K.-H., Näpänkangas, J. P., Mäkelä, J. T., Karttunen, T. J., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.456 · Cited by 244
Stimulatory versus suppressive effects of GM-CSF on tumor progression in multiple cancer types
Hong, I. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.64 · Cited by 240
Dietary Inflammatory Index and Colorectal Cancer Risk—A Meta-Analysis
Shivappa, N., Godos, J., Hébert, J. R., Wirth, M., Piuri, G., Speciani, A. F., & Grosso, G. (2017) · Nutrients · doi:10.3390/nu9091043 · Cited by 243
The gut microbiota in conventional and serrated precursors of colorectal cancer
Peters, B. A., Dominianni, C., Shapiro, J. A., Church, T. R., Wu, J., Miller, G., Yuen, E., Freiman, H. J., Lustbader, I., Salik, J., et al. (2016) · Microbiome · doi:10.1186/s40168-016-0218-6 · Cited by 233
Inflammation mobilizes copper metabolism to promote colon tumorigenesis via an IL-17-STEAP4-XIAP axis
Liao, Y., Zhao, J., Bulek, K., Tang, F., Chen, X., Cai, G., Jia, S., Fox, P. L., Huang, E. H., Pizarro, T. T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14698-y · Cited by 233
Proteome Profiling of Cancer-Associated Fibroblasts Identifies Novel Proinflammatory Signatures and Prognostic Markers for Colorectal Cancer
Torres, S., Bartolomé, R. A., Mendes, M. L., Barderas, R., Fernández‐Aceñero, M. J., Peláez‐García, A., Peña, C., López-Lucendo, M. F., Villar-Vázquez, R., de Herreros, A. G., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1130 · Cited by 234
Apolipoprotein A-I (ApoA-I), Immunity, Inflammation and Cancer
Georgila, K., Vyrla, D., & Drakos, E. (2019) · Cancers · doi:10.3390/cancers11081097 · Cited by 238
Animal models to study acute and chronic intestinal inflammation in mammals
Jiminez, J. A., Uwiera, T. C., Inglis, G. D., & Uwiera, R. R. E. (2015) · Gut Pathogens · doi:10.1186/s13099-015-0076-y · Cited by 220
TP53 gain-of-function mutation promotes inflammation in glioblastoma
Ham, S. W., Jeon, H.-Y., Jin, X., Kim, E.-J., Kim, J.-K., Shin, Y. J., Lee, Y., Kim, S. H., Lee, S. Y., Seo, S., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0126-3 · Cited by 213
Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer
Goc, J., Lv, M., Bessman, N. J., Flamar, A.-L., Sahota, S., Suzuki, H., Teng, F., Putzel, G., Eberl, G., Withers, D. R., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.029 · Cited by 214
The role of gut microbiota in the pathogenesis of colorectal cancer
Zhu, Q., Gao, R., Wu, W., & Qin, H. (2013) · Tumor Biology · doi:10.1007/s13277-013-0684-4 · Cited by 217
Inflammation and p53: A Tale of Two Stresses
Gudkov, A. V., Gurova, K. V., & Komarova, E. A. (2011) · Genes & Cancer · doi:10.1177/1947601911409747 · Cited by 211
The gastrointestinal microbiota and colorectal cancer
Keku, T. O., Dulal, S., Deveaux, A. E., Jovov, B., & Han, X. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00360.2012 · Cited by 207
Mesenchymal Cells in Colon Cancer
Koliaraki, V., Pallangyo, C. K., Greten, F. R., & Kollias, G. A. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.049 · Cited by 200
Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment
Hanus, M., Parada‐Venegas, D., Landskron, G., Wielandt, A. M., Hurtado, C., Álvarez, K., Hermoso, M. A., López-Köstner, F., & la Fuente, M. D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.612826 · Cited by 208
Potential Targets for Prevention of Colorectal Cancer: a Focus on PI3K/Akt/mTOR and Wnt Pathways
Pandurangan, A. K. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.4.2201 · Cited by 198
NF-κB in cancer therapy
Li, F., Zhang, J., Arfuso, F., Chinnathambi, A., Zayed, M. E., Alharbi, S. A., Kumar, A. P., Ahn, K. S., & Sethi, G. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1470-4 · Cited by 199
Plant secondary metabolites and gut health: the case for phenolic acids
Russell, W. R., & Duthie, G. G. (2011) · Proceedings of The Nutrition Society · doi:10.1017/s0029665111000152 · Cited by 198
IDO1 Metabolites Activate β-catenin Signaling to Promote Cancer Cell Proliferation and Colon Tumorigenesis in Mice
Thaker, A. I., Rao, M. S., Bishnupuri, K. S., Kerr, T. A., Foster, L. R., Marinshaw, J. M., Newberry, R. D., Stenson, W. F., & Ciorba, M. A. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.002 · Cited by 197
Long-term use of antibiotics and risk of colorectal adenoma
Cao, Y., Wu, K., Mehta, R. S., Drew, D. A., Song, M., Lochhead, P. J., Nguyen, L. H., Izard, J., Fuchs, C. S., Garrett, W. S., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313413 · Cited by 207
Mechanisms Linking Colorectal Cancer to the Consumption of (Processed) Red Meat: A Review
Demeyer, D. I., Mertens, B., SMET, S. D., & Ulens, M. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.873886 · Cited by 204
Occurrence and significance of tumor‐associated neutrophils in patients with colorectal cancer
Galdiero, M. R., Bianchi, P. P., Grizzi, F., Caro, G. D., Basso, G., Ponzetta, A., Bonavita, E., Barbagallo, M., Tartari, S., Polentarutti, N., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30076 · Cited by 197
Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
Aviello, G., Romano, B., Borrelli, F., Capasso, R., Gallo, L., Piscitelli, F., Marzo, V. D., & Izzo, A. A. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0856-x · Cited by 191
The mRNA Stability Factor HuR Inhibits MicroRNA-16 Targeting of COX-2
Young, L. E., Moore, A. E., Sokol, L., Meisner-Kober, N. C., & Dixon, D. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0337 · Cited by 198
Flavonoids in Cancer Metastasis
Líšková, A., Koklesová, L., Samec, M., Šmejkal, K., Samuel, S. M., Varghese, E., Abotaleb, M., Biringer, K., Kúdela, E., Danko, J., et al. (2020) · Cancers · doi:10.3390/cancers12061498 · Cited by 193
Interplay between DNA repair and inflammation, and the link to cancer
Kidane, D., Chae, W. J., Czochor, J. R., Eckert, K. A., Glazer, P. M., Bothwell, A. L. M., & Sweasy, J. B. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.875514 · Cited by 191
The Role of PPAR-δ in Metabolism, Inflammation, and Cancer: Many Characters of a Critical Transcription Factor
Liu, Y., Colby, J. K., Zuo, X., Jaoude, J. C., Wei, D., & Shureiqi, I. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113339 · Cited by 196
Roles of the Polyphenol–Gut Microbiota Interaction in Alleviating Colitis and Preventing Colitis-Associated Colorectal Cancer
Zhao, Y., & Jiang, Q. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa104 · Cited by 191
Dietary phytochemicals in colorectal cancer prevention and treatment: A focus on the molecular mechanisms involved
Afrin, S., Giampieri, F., Gasparrini, M., Forbes-Hernández, T. Y., Cianciosi, D., Reboredo‐Rodríguez, P., Zhang, J., Manna, P. P., Daglia, M., Atanasov, A. G., et al. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.011 · Cited by 187
IL-22 is related to development of human colon cancer by activation of STAT3
Jiang, R., Wang, H., Deng, L., Hou, J., Shi, R., Yao, M., Gao, Y., Yao, A., Wang, X., Yu, L., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-59 · Cited by 190

Authors: Terzić, J., Grivennikov, S., Karin, E., & Karin, M.
Affiliations: University of California San Diego (US)
Tel Aviv Sourasky Medical Center (IL)
Corresponding author: Karin, Michael
ORCID: Terzić, Janoš
Grivennikov, Sergei
Karin, Michael
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2010-05
Volume: 138
Issue: 6
Pages: 2101-2114.e5
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2010.01.058
OpenAlex: W2085852125
Cited by: 1,974
References: 247
Citations by year: 2026: 41 · 2025: 80 · 2024: 106 · 2023: 140 · 2022: 147 · 2021: 192 · 2020: 159 · 2019: 139 · 2018: 144 · 2017: 145 · 2016: 136 · 2015: 127 · 2014: 112 · 2013: 119 · 2012: 86
FWCI: 10.78
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
Crohn's and Colitis Foundation of America (1762)
American Association for Cancer Research
American Cancer Society
Topics: Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Keywords: inflammation, colon cancer, colorectal cancer, inflammatory bowel disease, colitis-associated colorectal cancer, carcinogenesis, immune cells, cytokines, cancer prevention, cancer therapy, metastasis
MeSH terms: Animals, Anti-Inflammatory Agents, Cell Transformation, Neoplastic, Colon, Colonic Neoplasms, Humans, Neoplasm Invasiveness, Risk Factors, Colorectal Neoplasms, Inflammatory Bowel Diseases, Signal Transduction, Gene Expression Regulation, Neoplastic, Cytokines, Anticarcinogenic Agents, Risk Assessment, Inflammation Mediators, Genetic Predisposition to Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Inflammation and Colon Cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks